Brief: Standard Biotools - Enters Termination, Waiver And Release Agreement With Illumina On July 24, 2026 - SEC Filing
BRIEF-Standard Biotools - Enters Termination, Waiver And Release Agreement With Illumina On July 24, 2026 - SEC Filing July 28 (Reuters) - Standard BioTools Inc LAB.O:
STANDARD BIOTOOLS - ENTERS TERMINATION, WAIVER AND RELEASE AGREEMENT WITH ILLUMINA ON JULY 24, 2026 - SEC FILING
STANDARD BIOTOOLS - RECEIVES ABOUT $30 MILLION IN CASH FROM ILLUMINA FOR WAIVER AND RELEASE OF OBLIGATIONS - SEC FILING
STANDARD BIOTOOLS - WAIVES RIGHTS TO 2026 ILLUMINA EARNOUT AND TERMINATES ROYALTY AND LICENSE AGREEMENTS - SEC FILING
Source text: []
Further company coverage: LAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Standard BioTools
See all newsBrief: Standard Biotools Announces Agreement To Sell Microfluidics Business To Archimed
Brief: Standard Biotools Provides Update On Sale Of Mass Cytometry Business
Standard BioTools Inc. reports results for the quarter ended June 30 - Earnings Summary
Standard BioTools Q2 revenue falls on consumables weakness
Brief: Standard BioTools Q2 EPS USD -0.07